IVF With Adenomyosis: Symptoms, Imaging, and Treatment Strategy

Adenomyosis can affect fertility by changing the structure and function of the uterus, but many patients can still pursue pregnancy with a careful IVF plan. Diagnosis usually relies on expert transvaginal ultrasound and, when needed, MRI, followed by individualized medical, surgical, or embryo transfer strategies.

Overview: What Adenomyosis Means for IVF

Adenomyosis is a benign gynecological condition in which tissue similar to the lining of the uterus is found within the muscular wall of the uterus. This can make the uterus enlarged, tender, or less flexible. For some patients, adenomyosis causes significant symptoms; for others, it is discovered during fertility testing or imaging before in vitro fertilization.

In the context of IVF treatment, adenomyosis matters because the uterus must be receptive to an embryo. Research suggests that adenomyosis may be associated with lower implantation rates, a higher chance of miscarriage, and some pregnancy complications. However, these associations do not mean that pregnancy is impossible. Many patients with adenomyosis conceive and have healthy pregnancies, especially when the condition is recognized and managed carefully.

The best strategy depends on several factors: the patient’s age, ovarian reserve, embryo quality, severity and pattern of adenomyosis, symptoms, previous IVF outcomes, and whether other conditions are present. Adenomyosis often overlaps with endometriosis, fibroids, or pelvic adhesions, so a complete fertility assessment is important before deciding on the timing of egg retrieval, embryo freezing, and embryo transfer.

Symptoms and How Adenomyosis Can Affect Fertility

The most common adenomyosis symptoms are heavy menstrual bleeding, painful periods, pelvic pressure, pain during intercourse, and chronic pelvic discomfort. Some patients also notice spotting before menstruation or worsening cramps over time. The uterus may feel enlarged on pelvic examination, although a normal examination does not rule out adenomyosis.

Adenomyosis can affect fertility in several possible ways. It may alter uterine contractions, increase inflammation in the uterine muscle, affect blood flow, or change the endometrial environment where implantation occurs. In some patients, the junctional zone between the endometrium and uterine muscle becomes thickened or irregular, which may influence embryo implantation.

Symptoms do not always match disease severity. A patient with severe pain may have limited disease on imaging, while another patient with few symptoms may have diffuse adenomyosis. This is why fertility planning should not rely on symptoms alone. Imaging, medical history, and previous fertility outcomes should be considered together.

• Symptoms that may suggest adenomyosis include progressively painful periods, heavy bleeding with clots, pelvic fullness, and pain that does not respond well to simple measures.
• Fertility clues may include repeated implantation failure, recurrent miscarriage, or unexplained infertility after other causes have been assessed.
• Associated conditions such as endometriosis, fibroids, or tubal disease can also contribute to infertility and should be evaluated.

Causes, Risk Factors, and Related Conditions

The exact cause of adenomyosis is not fully understood. Several theories have been proposed, including inward growth of endometrial tissue into the uterine muscle, tissue changes after uterine injury, developmental factors, and local hormone or inflammation-related mechanisms. Adenomyosis is considered estrogen-responsive, which helps explain why symptoms may change during reproductive years and often improve after menopause.

Risk factors can include increasing reproductive age, previous pregnancy, uterine surgery, cesarean delivery, and procedures involving the uterine lining, although adenomyosis can also occur in younger patients with no clear risk factor. Improved ultrasound and MRI techniques have made it easier to identify adenomyosis in patients seeking care for female infertility, including those in their 30s and early 40s.

Adenomyosis may be diffuse, involving a broad area of the uterine muscle, or focal, sometimes forming an adenomyoma that can resemble a fibroid. It may also coexist with endometriosis, a condition in which endometrial-like tissue grows outside the uterus. When these conditions are present together, treatment planning may need to address pelvic pain, ovarian cysts, adhesions, and embryo transfer timing as part of one coordinated plan.

Imaging and Diagnosis Before IVF

Transvaginal ultrasound is usually the first-line imaging test for suspected adenomyosis. When performed by an experienced clinician, it can identify features such as an enlarged or asymmetrical uterus, small myometrial cysts, fan-shaped shadowing, irregular junctional zone, or lines and buds extending from the endometrium into the uterine muscle. Three-dimensional ultrasound may provide additional information about the junctional zone.

MRI is not required for every patient, but it is useful when ultrasound findings are uncertain, when the uterus is difficult to assess, or when surgery is being considered. MRI can help distinguish adenomyosis from fibroids and map whether disease is focal or diffuse. It can also assess the thickness and appearance of the junctional zone, although interpretation should always be linked to symptoms and fertility goals.

Diagnosis before IVF should also include a broader fertility work-up. This may involve ovarian reserve testing, semen analysis, assessment of the uterine cavity, review of previous surgeries, and screening for other causes of infertility. A hysteroscopy or saline infusion ultrasound may be recommended if there is concern about polyps, submucosal fibroids, adhesions, or abnormalities inside the uterine cavity, because these can also affect embryo implantation.

No single imaging sign perfectly predicts IVF outcome. The most useful approach is to combine imaging severity with clinical context: patient age, embryo quality, number of previous transfers, bleeding pattern, pain level, and any history of miscarriage. This allows the care team to decide whether to proceed directly to IVF, treat symptoms first, freeze embryos, or delay transfer for uterine preparation.

Treatment Strategy Before IVF

Treatment for adenomyosis before IVF is individualized. For patients with mild imaging findings, few symptoms, good-quality embryos, and no history of failed transfers, a fertility specialist may recommend proceeding with IVF while monitoring the uterus carefully. For patients with diffuse disease, significant symptoms, repeated implantation failure, or miscarriage history, pre-transfer treatment may be considered.

Hormonal suppression is commonly used to quiet the adenomyotic tissue before embryo transfer. Options may include gonadotropin-releasing hormone agonists or antagonists, progestin-based therapy, or other hormonal approaches depending on the patient’s situation. These treatments are not suitable for everyone and temporarily prevent natural conception, so timing must be coordinated with egg retrieval, embryo freezing, and transfer planning.

Surgery is considered only in selected cases, usually when disease is focal and clearly distorts the uterine wall or cavity. Adenomyomectomy may reduce symptoms or improve uterine anatomy in carefully chosen patients, but it can also create scar tissue and may increase risks in a future pregnancy, including uterine rupture. For this reason, surgery requires detailed counseling by a gynecologic surgeon and fertility specialist. Hysterectomy is the definitive treatment for adenomyosis symptoms, but it is not an option for patients wishing to carry a pregnancy.

Additional care may include correction of anemia from heavy bleeding, pain management, treatment of coexisting endometriosis or fibroids, and optimization of general health before pregnancy. Patients should avoid starting supplements, hormonal medications, or anti-inflammatory regimens without medical advice, because some products may interfere with fertility treatment or early pregnancy.

IVF Planning: Egg Retrieval, Embryo Freezing, and Transfer

IVF planning with adenomyosis often separates embryo creation from embryo transfer. In many cases, the ovaries are stimulated first, eggs are retrieved, and embryos are frozen. This “freeze-all” approach allows time to prepare the uterus before a frozen embryo transfer, especially if hormonal suppression is recommended. It may also reduce the challenge of transferring an embryo in the same cycle as ovarian stimulation, when hormone levels are high.

The embryo transfer plan should consider both embryo factors and uterine factors. Embryo quality, patient age, genetic testing decisions, number of embryos available, and previous IVF history all influence success. Uterine preparation may involve a medicated or natural-cycle frozen embryo transfer protocol, depending on ovulation, hormone levels, and the physician’s assessment. There is no single best protocol for every patient with adenomyosis.

Some patients may also require advanced laboratory techniques when male factor infertility, low fertilization rates, or previous IVF history indicates a need. For example, intracytoplasmic sperm injection may be used when sperm parameters or prior fertilization outcomes suggest it is appropriate. This does not treat adenomyosis directly, but it may help address another part of the fertility picture.

Before transfer, the clinician may reassess the uterus with ultrasound to check size, tenderness, uterine lining pattern, and any changes after treatment. If adenomyosis remains very active or symptoms are severe, the care team may discuss delaying transfer, adjusting medication, or reassessing the diagnosis. The goal is to choose the moment when embryo quality and uterine readiness are best aligned.

Self-Care, Follow-Up, and When to See a Specialist

There is no proven self-care method that cures adenomyosis, but supportive steps can improve comfort and readiness for fertility treatment. Patients with heavy bleeding should be evaluated for iron deficiency or anemia. A balanced diet, regular movement, smoking cessation, adequate sleep, and management of chronic conditions such as thyroid disease or diabetes can support general reproductive health.

Patients should seek specialist care if they have very painful or heavy periods, pelvic pain affecting daily life, infertility lasting 12 months or longer, infertility after age 35 lasting 6 months or longer, recurrent miscarriage, or previous unsuccessful embryo transfers. Earlier evaluation is appropriate when symptoms are severe or when imaging has already suggested adenomyosis, endometriosis, or fibroids.

A multidisciplinary approach can be helpful when adenomyosis affects both symptoms and fertility. Gynecologists, fertility specialists, radiologists, embryologists, and pregnancy-care specialists may all contribute to planning. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat fertility-related conditions, including infertility, for international patients seeking coordinated evaluation and care.

Frequently asked questions

Can IVF work if a patient has adenomyosis?

Yes, IVF can work for patients with adenomyosis, although outcomes vary. Success depends on age, ovarian reserve, embryo quality, the severity of adenomyosis, and whether other conditions are present. A tailored plan may include imaging, medical treatment before transfer, or embryo freezing.

Does adenomyosis always need treatment before embryo transfer?

Not always. Mild adenomyosis without significant symptoms or previous implantation problems may not require pre-treatment. More active or diffuse disease, severe symptoms, or repeated failed transfers may lead the doctor to recommend hormonal suppression or another strategy before transfer.

Is ultrasound or MRI better for diagnosing adenomyosis?

Expert transvaginal ultrasound is usually the first imaging test and can be highly informative. MRI is useful when ultrasound findings are unclear, when the uterus has fibroids, or when surgical planning is being considered. The best choice depends on the clinical situation and local expertise.

Can adenomyosis cause miscarriage?

Adenomyosis has been associated with a higher risk of miscarriage in some studies, but it is not the only factor that influences pregnancy loss. Embryo chromosome status, age, uterine cavity findings, hormone balance, and other medical conditions also matter. Patients with recurrent miscarriage should have a complete evaluation.

Is surgery recommended for adenomyosis before IVF?

Surgery is not routinely recommended for all patients with adenomyosis. It may be considered for selected focal disease, especially if the uterine shape is affected or symptoms are severe. Because uterine surgery can carry risks for future pregnancy, the benefits and risks should be reviewed carefully.

How long should a patient wait after adenomyosis treatment before IVF transfer?

The timing depends on the treatment used and the patient’s response. Hormonal suppression may last for a few months, while recovery after surgery can require a longer delay before pregnancy is considered. The fertility specialist will plan transfer timing based on imaging, symptoms, and overall treatment goals.

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.